Tyzepa Injection 2.5 mg/0.5 ml contains Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is a novel therapeutic agent for type 2 diabetes mellitus, particularly suited for patients needing improved glycemic control and weight management. Tirzepatide works through complementary mechanisms, targeting both the GIP and GLP-1 pathways to regulate blood sugar, support metabolic health, and reduce appetite.

This lower starting dose of 2.5 mg is typically used as an initiation or titration dose to enhance tolerability and minimize gastrointestinal side effects. Regular use of Tyzepa, along with lifestyle interventions, supports sustained glucose control and improved metabolic outcomes in adults with type 2 diabetes.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Tirzepatide 2.5 mg per 0.5 ml prefilled injection

Mechanism of Action

Tirzepatide acts as a dual incretin receptor agonist, producing multiple effects that support glycemic regulation:

1. GIP receptor activation – Stimulates glucose-dependent insulin secretion and helps regulate lipid metabolism.

2. GLP-1 receptor activation – Promotes insulin secretion in response to meals, suppresses glucagon release, slows gastric emptying, and increases satiety.

3. Synergistic effect – Reduces fasting and postprandial glucose levels while supporting weight management through appetite suppression and improved energy metabolism.

By targeting two key incretin pathways, Tirzepatide provides superior glucose-lowering effects compared to single incretin therapies and may contribute to cardiovascular and metabolic benefits in type 2 diabetes patients.

Indications

Tyzepa Injection 2.5 mg/0.5 ml is indicated for:

• Type 2 diabetes mellitus – as initial therapy or part of combination therapy to improve glycemic control

• Weight management – in overweight or obese patients with type 2 diabetes, alongside diet and exercise

• Adjunct therapy – for patients inadequately controlled with oral antidiabetic agents or lifestyle measures

It is intended for subcutaneous use under medical supervision, ensuring proper titration and monitoring.

Dosage and Administration

• Starting dose: 2.5 mg once weekly, administered subcutaneously in the abdomen, thigh, or upper arm.

• Dose is typically increased gradually, based on patient response and tolerability, as directed by a physician.

• Rotate injection sites to reduce the risk of local reactions.

• Administer at the same time each week for consistent glucose control.

• Regular blood glucose monitoring and adherence to diet and exercise are essential for optimal results.

Benefits

• Helps achieve effective glycemic control in type 2 diabetes

• Reduces both fasting and postprandial blood sugar levels

• Supports weight loss and appetite management

• Convenient once-weekly dosing enhances adherence

• May provide cardiovascular and metabolic benefits beyond glucose control

Precautions

• Use with caution in patients with a history of pancreatitis, severe gastrointestinal disorders, or thyroid disease.

• Not suitable for type 1 diabetes or diabetic ketoacidosis.

• Monitor for hypoglycemia if used in combination with insulin or sulfonylureas.

• Avoid in patients with hypersensitivity to Tirzepatide or any component of the injection.

• Pregnancy and breastfeeding: only use if clearly indicated by a physician.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects:

• Nausea, vomiting, or diarrhea

• Reduced appetite or early satiety

• Injection site reactions such as redness or mild swelling

• Headache or fatigue

Rare but serious side effects:

• Pancreatitis

• Severe gastrointestinal disturbances

• Allergic reactions

Storage

• Store in a refrigerator at 2–8°C

• Do not freeze

• Keep the prefilled pen in its original packaging to protect from light

• Keep out of reach of children

Tyzepa Injection 2.5 mg/0.5 ml provides a safe and effective initiation dose for type 2 diabetes, enabling gradual titration while offering dual incretin benefits for blood sugar control, weight management, and improved metabolic health.